JP2004517630A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004517630A5 JP2004517630A5 JP2002558463A JP2002558463A JP2004517630A5 JP 2004517630 A5 JP2004517630 A5 JP 2004517630A5 JP 2002558463 A JP2002558463 A JP 2002558463A JP 2002558463 A JP2002558463 A JP 2002558463A JP 2004517630 A5 JP2004517630 A5 JP 2004517630A5
- Authority
- JP
- Japan
- Prior art keywords
- antisense compound
- antisense
- src
- composition according
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/723,535 US6355483B1 (en) | 2000-11-27 | 2000-11-27 | Antisenses inhibition of SRC-2 expression |
| PCT/US2001/044216 WO2002057409A2 (en) | 2000-11-27 | 2001-11-26 | Antisense modulation of src-2 expression |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004517630A JP2004517630A (ja) | 2004-06-17 |
| JP2004517630A5 true JP2004517630A5 (cg-RX-API-DMAC7.html) | 2005-05-19 |
Family
ID=24906673
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002558463A Withdrawn JP2004517630A (ja) | 2000-11-27 | 2001-11-26 | Ｓｒｃ−２発現のアンチセンスモジュレーション |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US6355483B1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1346065A2 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2004517630A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2002245030A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2002057409A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6355483B1 (en) * | 2000-11-27 | 2002-03-12 | Isis Pharmaceuticals, Inc. | Antisenses inhibition of SRC-2 expression |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5801154A (en) * | 1993-10-18 | 1998-09-01 | Isis Pharmaceuticals, Inc. | Antisense oligonucleotide modulation of multidrug resistance-associated protein |
| US5734039A (en) * | 1994-09-15 | 1998-03-31 | Thomas Jefferson University | Antisense oligonucleotides targeting cooperating oncogenes |
| US6268173B1 (en) * | 1996-07-12 | 2001-07-31 | Institut Natural De La Sante Et La Recherche Medicale | Polynucleotide encoding transcriptional intermediary factor-2 |
| WO1998056806A1 (en) * | 1997-06-12 | 1998-12-17 | The Regents Of The University Of California | A TRANSCRIPTION FACTOR COACTIVATOR PROTEIN, p/CIP |
| US5951455A (en) * | 1998-12-04 | 1999-09-14 | Isis Pharmaceuticals, Inc. | Antisense modulation of G-alpha-11 expression |
| US6355483B1 (en) * | 2000-11-27 | 2002-03-12 | Isis Pharmaceuticals, Inc. | Antisenses inhibition of SRC-2 expression |
-
2000
- 2000-11-27 US US09/723,535 patent/US6355483B1/en not_active Expired - Lifetime
-
2001
- 2001-11-26 JP JP2002558463A patent/JP2004517630A/ja not_active Withdrawn
- 2001-11-26 WO PCT/US2001/044216 patent/WO2002057409A2/en not_active Ceased
- 2001-11-26 AU AU2002245030A patent/AU2002245030A1/en not_active Abandoned
- 2001-11-26 EP EP01993172A patent/EP1346065A2/en not_active Withdrawn